From development to dysfunction: microglia and the complement cascade in CNS homeostasis

scientific article

From development to dysfunction: microglia and the complement cascade in CNS homeostasis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ARR.2013.02.001
P3181OpenCitations bibliographic resource ID2033133
P932PMC publication ID3700678
P698PubMed publication ID23419464
P5875ResearchGate publication ID235658114

P50authorMatthew ZabelQ57425681
P2093author name stringWolff M Kirsch
P2860cites workMicroglial interactions with synapses are modulated by visual experienceQ27322943
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivoQ27860578
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.Q37941009
Rational heterodoxy: cholesterol reformation of the amyloid doctrineQ38024542
Review: microglia of the aged brain: primed to be activated and resistant to regulationQ38049597
Microglia instruct subventricular zone neurogenesisQ40231614
Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.Q40496060
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.Q40657503
Complement component C1q modulates the phagocytosis of Abeta by microgliaQ41720670
Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic miceQ42001466
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brainQ42477525
Differential distribution and activation of microglia in the brain of male C57BL/6J miceQ42511099
Plaque complement activation and cognitive loss in Alzheimer's diseaseQ43111970
C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation.Q43187968
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's diseaseQ43249892
Characterization of ameboid microglia isolated from developing mammalian brain.Q43766815
The Microglial Reaction in the Rat Dorsal Hippocampus following Transient Forebrain IschemiaQ43830901
Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptorQ44207850
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.Q44241464
Localization and cell association of C1q in Alzheimer's disease brainQ44252091
Neuronal localization of C1q in preclinical Alzheimer's diseaseQ44748605
Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.Q46691360
Microglia promote the death of developing Purkinje cellsQ48016378
Evidence for synaptic stripping by cortical microgliaQ48351803
What is immune privilege (not)?Q48356667
Potentiation of cortical inhibition by visual deprivation.Q48438986
Neurons express proteins of the classical complement pathway in Alzheimer disease.Q48592170
Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brainQ48616075
Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.Q48677054
Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.Q48882573
Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude.Q48912035
Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.Q49090173
Comparison of the effects of unilateral and bilateral eye closure on cortical unit responses in kittensQ51245933
Long-term synapse loss induced by focal blockade of postsynaptlc receptorsQ59069374
Displacement of synaptic terminals from regenerating motoneurons by microglial cellsQ72179911
Microglial motility in the rat facial nucleus following peripheral axotomyQ73681218
Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxisQ79772775
Structural and functional evidence for microglial expression of C1qR(P), the C1q receptor that enhances phagocytosisQ28143328
The classical complement cascade mediates CNS synapse eliminationQ28261273
Microglia sculpt postnatal neural circuits in an activity and complement-dependent mannerQ28267444
A new class of membrane-bound chemokine with a CX3C motifQ28303204
Control of microglial neurotoxicity by the fractalkine receptorQ28513748
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microgliaQ28573077
Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged ratsQ28576101
Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12.Q28584742
Synaptic pruning by microglia is necessary for normal brain developmentQ29615591
Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminalsQ29619476
Microglia: a sensor for pathological events in the CNSQ29620556
Genetic variation at CR1 increases risk of cerebral amyloid angiopathyQ30422717
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticityQ30467724
Enhanced synaptic connectivity and epilepsy in C1q knockout miceQ30494456
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosisQ33560182
C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine productionQ33601747
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's miceQ34076162
Regulation of tau pathology by the microglial fractalkine receptorQ34179654
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosisQ34554154
Migration and differentiation of neural precursor cells can be directed by microgliaQ34794137
CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosisQ34796584
CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.Q35213298
Structural transitions of complement component C3 and its activation productsQ35544520
C3-dependent mechanism of microglial priming relevant to multiple sclerosis.Q35734866
Immune signalling in neural development, synaptic plasticity and diseaseQ35811897
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosisQ36298197
A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.Q36652260
Neurotransmitter receptors on microglia.Q36955350
Debris clearance by microglia: an essential link between degeneration and regeneration.Q37092476
Microglial clearance function in health and diseaseQ37222916
C1q: the perfect complement for a synaptic feast?Q37283459
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's diseaseQ37331433
Neurotransmission selectively regulates synapse formation in parallel circuits in vivoQ37353006
Immune proteins in brain development and synaptic plasticity.Q37617631
Synapse formation and maintenance by C1q family proteins: a new class of secreted synapse organizers.Q37774409
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmicrogliaQ1622829
P304page(s)749-756
P577publication date2013-02-16
P1433published inAgeing Research ReviewsQ762802
P1476titleFrom development to dysfunction: microglia and the complement cascade in CNS homeostasis
P478volume12

Reverse relations

cites work (P2860)
Q44817276'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared
Q35825824APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.
Q40758347Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii
Q37305891Autophagy resolves early retinal inflammation in Igf1-deficient mice
Q90429677Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases
Q64997810Complement C3 Inhibition Modulates Neurodegeneration in Chronic Traumatic Brain Injury.
Q47612261Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline.
Q57039780Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Q40246258Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection
Q37356880Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.
Q93170074Developmental roles of microglia: A window into mechanisms of disease
Q38198928Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases
Q36889750Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress
Q30355850Function and Dysfunction of Microglia during Brain Development: Consequences for Synapses and Neural Circuits
Q46972859Glia activation and its role in oxidative stress.
Q38599803In Vitro Models for Neurogenesis.
Q92626425Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction
Q34630522Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment
Q59335641Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
Q55308149Mice lacking galectin-3 (Lgals3) function have decreased home cage movement.
Q38432342Microarray analysis of aging-associated immune system alterations in the rostral ventrolateral medulla of F344 rats.
Q89522833Microglia and Parkinson's disease: footprints to pathology
Q47548797Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system
Q49804316New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.
Q90184025P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis
Q35662879RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
Q36209324Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins.
Q33651921Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorder
Q64087538Significance of Complement System in Ischemic Stroke: A Comprehensive Review
Q34545200Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease
Q47889401The Complement System and Preeclampsia
Q38210510The role of microglial activation in disease progression
Q26861263The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Q35698522Therapeutic potential of mGluR5 targeting in Alzheimer's disease
Q64099194Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes

Search more.